← Back to Analyst Consensus 
PHIN Buy
PHINIA INC.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 31, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jun 12, 2026 | Keybanc | initiate | — → Overweight | — | 52% |
| Feb 26, 2026 | Freedom Broker | downgrade | Buy → Hold | — | 59% |
| Jan 16, 2026 | Freedom Broker | initiate | — → Buy | — | 59% |
| Jan 16, 2026 | Freedom Capital Markets | initiate | — → Buy | — | 43% |
| Jan 14, 2026 | UBS | maintain | Neutral → Neutral | $71 | 54% |
| Dec 30, 2025 | Northland Capital Markets | maintain | Outperform → Outperform | $79 | 50% |
| Oct 29, 2025 | UBS | maintain | Neutral → Neutral | $59 | 54% |
| Oct 6, 2025 | UBS | maintain | Neutral → Neutral | $62 | 54% |
| Sep 10, 2025 | B of A Securities | maintain | Buy → Buy | $64 | 53% |
| Aug 12, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $48 | 54% |
| Jul 25, 2025 | UBS | maintain | Neutral → Neutral | $55 | 54% |
| Jul 14, 2025 | UBS | maintain | Neutral → Neutral | $52 | 54% |
| May 19, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $46 | 54% |
| May 15, 2025 | B of A Securities | maintain | Buy → Buy | $55 | 53% |
| Apr 10, 2025 | UBS | downgrade | Buy → Neutral | $45 | 54% |
| Apr 10, 2025 | B of A Securities | initiate | — → Buy | $53 | 53% |
| Mar 24, 2025 | CL King | initiate | — → Buy | $54 | 50% |
| Jan 30, 2025 | Northland Capital Markets | initiate | — → Outperform | $61 | 50% |
| Jan 16, 2025 | UBS | maintain | Buy → Buy | $57 | 54% |
| Sep 25, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $50 | 54% |
| Sep 4, 2024 | UBS | initiate | — → Buy | $55 | 54% |
| Mar 12, 2024 | Morgan Stanley | initiate | — → Overweight | $50 | 54% |
| Mar 11, 2024 | Morgan Stanley | initiate | — → Overweight | $50 | 54% |
| Sep 5, 2023 | Exane BNP Paribas | initiate | — → Outperform | $36 | 52% |
Price Target Trend
Apr 9, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days